Research Topics
Genomes and Genes | F BarkhofSummaryAffiliation: VU University Medical Center Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Imaging of white matter lesionsFrederik Barkhof
Department of Radiology, Vrije University Medical Centre, Amsterdam, The Netherlands
Cerebrovasc Dis 13:21-30. 2002..Spinal cord lesions are very common in MS, but do not occur in normal ageing nor in small vessel disease...
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trialsF Barkhof
Department of Radiology, VU Medical Centre, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 65:1447-54. 2005..Knowledge about predictors of enhancement status is important for the selection of patients for MRI monitored trials...
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very oldF Barkhof
Department of Radiology, VU University Medical Centre, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 69:1521-7. 2007..Medial temporal lobe atrophy (MTA) is a sensitive radiologic marker for Alzheimer disease (AD) and associated with cognitive impairment. The value of MTA in the oldest old (>85 years old) is largely unknown...
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trialsFrederik Barkhof
VU University Medical Centre, Amsterdam, The Netherlands
Nat Rev Neurol 8:13-21. 2012..Finally, we address safety considerations in the use of MRI in MS trials, and the safety-related responsibilities of the various parties involved in conducting such trials...
Visual assessment of posterior atrophy development of a MRI rating scaleEsther L G E Koedam
Department of Neurology and Alzheimer Centre, VU University Medical Centre, PO Box 7057, 1007 MB, Amsterdam, The Netherlands
Eur Radiol 21:2618-25. 2011..To develop a visual rating scale for posterior atrophy (PA) assessment and to analyse whether this scale aids in the discrimination between Alzheimer's disease (AD) and other dementias...
MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndromeJessica M Nielsen
MS Center, Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
BMC Neurol 9:19. 2009..Here we assess the predictive value of clinically defined dissemination in space at first presentation for time to clinically definite MS (CDMS)...
MRI--the perfect surrogate marker for multiple sclerosis?Frederik Barkhof
MS Center Amsterdam and Department of Radiology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Nat Rev Neurol 5:182-3. 2009..Many short-term studies fail to appreciate the relationship between MRI and clinical findings, although such shortcomings might be argued to reflect a weakness of clinical measures, rather than of MRI...
The Holy Grail in diagnostic neuroradiology: 3T or 3D?Frederik Barkhof
Department of Radiology, VU University Medical Center, P O Box 7057, 1008 MB, Amsterdam, The Netherlands
Eur Radiol 21:449-56. 2011....
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1aFrederik Barkhof
MS MRI Centre and Department of Radiology, VU Medical Centre, Amsterdam, The Netherlands
Ann Neurol 53:718-24. 2003..6 in patients with four positive criteria. However, the study was not powered to detect statistically significant treatment by variable interaction, and this remains an important issue for further study...
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearanceFrederik Barkhof
Dutch MR MS Center, and Department of Radiology, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Arch Neurol 60:1073-81. 2003..Various types of pathologic mechanisms in multiple sclerosis (MS) can alter magnetic resonance imaging (MRI) signals, and the appearance of remyelinated lesions on MRI is largely unknown...
Guidelines for brain imaging in vascular dementia clinical trialsFrederik Barkhof
Image Analysis Centre, VU Medical Centre, Amsterdam, The Netherlands
Int Psychogeriatr 15:273-6. 2003..In clinical trials, standardized acquisition protocols and central data analysis are mandatory. More work is needed to determine the natural progression in VaD and the possible use of MRI-based outcome measures...
Imaging outcomes for neuroprotection and repair in multiple sclerosis trialsFrederik Barkhof
Department of Radiology and Amsterdam MS Center, VU University Medical Center, Amsterdam, The Netherlands
Nat Rev Neurol 5:256-66. 2009..Power calculations show that these outcome measures can be applied with attainable sample sizes...
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?F Barkhof
Department of Radiology, VU University Medical Center, MB, Amsterdam, The Netherlands
Neurology 74:1033-40. 2010..This study evaluated the safety, tolerability, and effects on MRI parameters of 2 different doses of ibudilast in relapsing forms of MS...
Assessing treatment effects on axonal loss--evidence from MRI monitored clinical trialsFrederik Barkhof
Department of Diagnostic Radiology, VU Medical Centre, De Boelelaan 1117, 7057, Amsterdam 1007 MB, The Netherlands
J Neurol 251:IV6-12. 2004..At the same time it illustrates the difficulties in understanding the mechanisms leading to axonal loss and persistent clinical deficit...
Whole-brain T1-relaxation time measurements in multiple sclerosisFrederik Barkhof
MR-MS Center, Department of Radiology, VU Medical Center, Amsterdam, The Netherlands
J Neurol 249:1451-2. 2002
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year resultsFrederik Barkhof
Department of Diagnostic Radiology and Image Analysis Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Arch Neurol 64:1292-8. 2007....
The clinico-radiological paradox in multiple sclerosis revisitedFrederik Barkhof
MR MS Center, Department of Radiology, VU Medical Center, 1007 MB Amsterdam, The Netherlands
Curr Opin Neurol 15:239-45. 2002..This corroborates with conventional wisdom that one should not rely on a single magnetic resonance measure, but take full advantage of the fact that magnetic resonance is able to provide multidimensional information...
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer diseaseW J P Henneman
Department of Radiology and Alzheimer Center, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
Neurology 73:935-40. 2009....
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairmentL A van de Pol
Department of Neurology, Alzheimer Centre, VU Medical Centre, Amsterdam, The Netherlands
Neurology 69:1491-7. 2007..We compared baseline clinical, neuropsychological, and MRI measures to characterize these MCI subgroups...
Whole-brain atrophy rate in Alzheimer disease: identifying fast progressorsJ D Sluimer
Department of Radiology and Alzheimer Centre, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 70:1836-41. 2008..To assess which baseline clinical and MRI measures influence whole-brain atrophy rates, measured from serial MR imaging...
Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosisM A van Walderveen
Magnetic Resonance Center for Multiple Sclerosis Research, University Hospital Vrije Universiteit, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Arch Neurol 58:76-81. 2001..Clinical determinants of T1 lesions may differ between subgroups of patients with MS and subsequently may have implications for the selection of patients for clinical trials...
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic populationF H Bouwman
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 30:1-7. 2010..This study applies the criteria in a memory clinic population, using clinical criteria as the reference criterion...
[Alpha]B-crystallin genotype has impact on the multiple sclerosis phenotypeT van Veen
Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurology 61:1245-9. 2003..Alpha]B-crystallin is a candidate autoantigen in MS, and there are three polymorphisms in the promoter region of the encoding gene (CRYAB): at positions -C249G, -C650G, and -A652G...
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measuresW J P Henneman
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
Neurology 72:999-1007. 2009..To investigate the added value of hippocampal atrophy rates over whole brain volume measurements on MRI in patients with Alzheimer disease (AD), patients with mild cognitive impairment (MCI), and controls...
Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behaviorR Goekoop
Department of Neurology, VU University Medical Center, De Boelelaan 1117 1081 HV, Amsterdam, The Netherlands
Neuroimage 25:63-75. 2005..Further neuropsychological assessment is necessary to test the validity of these predictions...
Predicting short-term disability progression in early multiple sclerosis: added value of MRI parametersA Minneboo
MS Center of the VU University Medical Center, Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 79:917-23. 2008..The aim of this study was to investigate whether adding MRI parameters to a model with only clinical parameters could improve these associations...
CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimagingY A L Pijnenburg
Alzheimer Center, Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 77:246-8. 2006..CSF Abeta42 variability remained unexplained. Future research could study the role of ApoE genotype and Abeta42 in FTLD, as well as establish measures for disease intensity...
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairmentF H Bouwman
Department of Neurology, Alzheimer Centre, VU Medical Center, MB Amsterdam, The Netherlands
Neurobiol Aging 28:1070-4. 2007..To study CSF biomarkers, beta-amyloid(1-42) (Abeta(1-42)) and tau, and medial temporal lobe atrophy (MTA) on MRI in their ability to predict dementia in patients with mild cognitive impairment (MCI)...
Incidence of cerebral microbleeds: a longitudinal study in a memory clinic populationJ D C Goos
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurology 74:1954-60. 2010..Cerebral microbleeds (MBs) are commonly observed in memory clinic patients. Little is known about occurrence of and risk factors for developing new MBs in this population...
Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of diseaseH Vrenken
Department of Radiology, MR Center for MS Research, VU University Medical Center, Amsterdam, The Netherlands
Mult Scler 13:708-16. 2007..We conclude that disease-induced MTR changes were small in MS NAWM and NAGM, but did correlate with clinical decline, lesion volume and overall cerebral atrophy...
Accumulation of cortical lesions in MS: relation with cognitive impairmentS D Roosendaal
Department of Radiology, MS Center Amsterdam, VU University Medical Center, The Netherlands
Mult Scler 15:708-14. 2009..However, little is known about progression of GM lesions over time...
Postmortem verification of MS cortical lesion detection with 3D DIRA Seewann
Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurology 78:302-8. 2012..To assess the sensitivity and specificity of 3D double inversion recovery (DIR) MRI for detecting multiple sclerosis (MS) cortical lesions (CLs) using a direct postmortem MRI to histopathology comparison...
Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?T Korteweg
Department of Radiology, VU University Medical Centre, Amsterdam, The Netherlands
Mult Scler 15:465-71. 2009..Multiple sclerosis (MS) is characterized, besides focal lesions, by brain atrophy. The determinants of atrophy rates in individual patients are poorly understood...
Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registrationL A van de Pol
Department of Neurology, Alzheimer Centre, VU Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neuroimage 34:1036-41. 2007..This method may be useful to quantify hippocampal volume change, given the reduction in operator time and improved precision...
Cognitive slowing in multiple sclerosis is strongly associated with brain volume reductionR H C Lazeron
Department of Neurology, Vrije Universiteit Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Mult Scler 12:760-8. 2006..Since MS is characterized by cognitive slowing rather than impaired accuracy, we used the Amsterdam Neuropsychological Tasks (ANT) program, a computerized test proven to be very sensitive to cognitive slowing in MS patients...
Association between MRI parameters and the MS severity scale: a 12 year follow-up studyA Minneboo
Department of Radiology, MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
Mult Scler 15:632-7. 2009..Until now, these studies are relatively sparse and, therefore, the predictive value of MRI parameters for clinical disability remains largely unknown...
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosisI J van den Elskamp
Department of Radiology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Mult Scler 16:660-9. 2010..Recovery of lesion MTR is a feasible outcome measure for future multicentre clinical trials measuring the effect of remyelinating agents...
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatmentF Barkhof
MR MS centre, VU Medical Centre, Amsterdam, The Netherlands
Brain 124:1396-402. 2001..In patients with SP multiple sclerosis, IFNbeta-1b treatment reduces the development of hypointense T(1) lesions, suggesting that reduced axonal damage in lesions may play a part in the beneficial effect that is observed clinically...
Normal-appearing white matter changes vary with distance to lesions in multiple sclerosisH Vrenken
Department of Radiology, MR Center for MS Research, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 27:2005-11. 2006..We aimed to investigate the relationship of NAWM changes to the distance to the lesions...
Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophyM J Eikelenboom
Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
Neurology 60:219-23. 2003..To evaluate markers of axonal damage in CSF and serum of patients with different subtypes of MS in relation to measures of disease progression on MRI...
Prevalence and severity of microbleeds in a memory clinic settingC Cordonnier
Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Neurology 66:1356-60. 2006..This finding of a relatively high proportion of MBs in Alzheimer disease and mild cognitive impairment provides further evidence for the involvement of vascular factors in neurodegenerative diseases such as Alzheimer disease...
Neurological signs in relation to white matter hyperintensity volumes in memory clinic patientsS S Staekenborg
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands s staekenborg vumc nl
Dement Geriatr Cogn Disord 29:301-8. 2010..To determine the frequency of neurological signs in a memory clinic population and to explore their associations with white matter hyperintensity (WMH)...
Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patientsA Minneboo
MR Center for MS Research, VU University Medical Center, Amsterdam, The Netherlands
Neurology 65:56-61. 2005..It is unclear whether the same applies to the evolution of lesions on T1-weighted MRI...
Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MSL F van der Voort
VU Medical Center, Department of Neurology, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 75:1228-33. 2010..To determine if myxovirus resistance protein A (MxA) mRNA is related to clinical disease activity in multiple sclerosis (MS)...
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progressionA A Gouw
Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Cerebrovasc Dis 25:247-53. 2008..However, the most suitable method for measuring WMH progression has not been established yet. We compared the reliability and sensitivity of cross-sectional and longitudinal visual scales with volumetry for measuring WMH progression...
Reduced resting-state brain activity in the "default network" in normal agingJ S Damoiseaux
Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
Cereb Cortex 18:1856-64. 2008..The relevance of these findings is illustrated by the correlation between reduced activity of one of these RSNs and less effective executive functioning/processing speed in the older group...
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosisI J van den Elskamp
Department of Radiology, MS Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
Neuroradiology 52:875-81. 2010....
Clinical correlations of brain lesion distribution in multiple sclerosisM M Vellinga
Department of Neurology, MS Center Amsterdam, Amsterdam, The Netherlands
J Magn Reson Imaging 29:768-73. 2009..Hypothesizing that symptomatology may partly be determined by lesion location, this retrospective study explored relations between lesion location and disability using voxelwise analyses in standard space...
Quantitative MR imaging and spectroscopy in congenital cytomegalovirus infection and periventricular leukomalacia suggests a comparable neuropathological substrate of the cerebral white matter lesionsJ P van der Voorn
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Neuropediatrics 40:168-73. 2009..Congenital CMV infection and PVL affect the cerebral white matter in the same developmental period when immature oligodendrocytes are particularly vulnerable...
Optimizing the association between disability and biological markers in MSN F Kalkers
MS MRI Center, VU Medical Center, Amsterdam, The Netherlands
Neurology 57:1253-8. 2001..The authors studied the relation of brain volume measurements with the MS Functional Composite (MSFC) in an attempt to improve the clinico-radiologic association...
Anterior medial temporal lobe activation during attempted retrieval of encoded visuospatial scenes: an event-related fMRI studyS A Rombouts
Department of Clinical Physics and Informatics, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Neuroimage 14:67-76. 2001..We conclude that the left posterior parahippocampal gyrus responds during encoding, while on the other hand the left anterior parahippocampal gyrus and the right anterior hippocampus were more strongly involved in retrieval...
Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volumeA M Wessels
Department of Medical Psychology, VU University Medical Centre, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
Diabetologia 50:1763-9. 2007....
Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MSL M L van Winsen
Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
J Neuroimmunol 186:150-5. 2007..We investigated the influence of these polymorphisms on clinical and MRI parameters. The ER22/23EK polymorphism was associated with a more aggressive MS phenotype, measured both clinically and on MRI...
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS studyA A Gouw
Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
J Neurol 253:1189-96. 2006..The most suitable method to assess WMH in relation to the clinical evaluation of disturbances in these areas has not yet been established...
Regional DTI differences in multiple sclerosis patientsS D Roosendaal
Department of Radiology, MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
Neuroimage 44:1397-403. 2009..TBSS can be useful in future studies with other MS patient samples to provide an unbiased localization of damage and generate location-specific hypotheses...
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patientsM M Vellinga
Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
Neurology 70:1150-1. 2008
Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cellsJ Killestein
Department of Immunobiology, CLB and Laboratory of Experimental and Clinical Immunology of the University of Amsterdam, Amsterdam, The Netherlands
J Neuroimmunol 118:286-94. 2001..However, the exact mechanisms by which T cells and cytokines contribute to disease activity remain to be clarified...
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathologyA A Gouw
Department of Neurology, Alzheimer Center and Image Analysis Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Brain 131:3286-98. 2008..Quantitative MRI techniques reveal differences in WMH between Alzheimer's disease and non-demented elderly, and are able to reflect the severity of the neuropathological changes involved...
Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristicsJ N P Zwemmer
Department of Neurology, MS Center, VU University Medical Center, Amsterdam, The Netherlands
Mult Scler 12:565-72. 2006..While clinical subtypes differ by magnetic resonance imaging (MRI) signature on a group level, a classification of individual MS patients based purely on MRI characteristics has not been presented so far...
Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosisR H C Lazeron
MS Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Mult Scler 11:524-31. 2005..In conclusion, cognitive impairment in MS is moderately dependent on amount (and distribution) of structural brain damage, especially in the more physically impaired patients group...
T1 hypointensities and axonal lossF Barkhof
Department of Radiology, Multiple Sclerosis MRI Research Centre Amsterdam, Vrije Universiteit Hospital, 1007 MB Amsterdam, The Netherlands
Neuroimaging Clin N Am 10:739-52 ,ix. 2000..They correlate better with clinical disability than T2-weighted images, are found in patients with progressive multiple sclerosis, and can be used as surrogate outcome measures in treatment trials...
Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examinationJ C J Bot
MR Center for MS Research, Departments of Radiology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Neurology 62:226-33. 2004....
Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's diseaseL Gootjes
Department of Clinical Neuropsychology, Vrije Universiteit, Amsterdam, The Netherlands
Neuropsychologia 44:208-17. 2006..Difficulties to attend specifically to the left ear during dichotic listening in some of the AD patients, points at decreased attention and executive functions and suggests that pathology of specifically the frontal areas is involved...
Global and local gray matter loss in mild cognitive impairment and Alzheimer's diseaseG B Karas
Department of Diagnostic Radiology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Neuroimage 23:708-16. 2004..Mild cognitive impairment (MCI) is thought to be the prodromal phase to Alzheimer's disease (AD). We analyzed patterns of gray matter (GM) loss to examine what characterizes MCI and what determines the difference with AD...
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS studyE S C Korf
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Diabet Med 24:166-71. 2007....
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA studyL A van de Pol
VUMC, Department of Neurology, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 80:1069-74. 2009..Clinical subtypes of mild cognitive impairment (MCI) may represent different underlying aetiologies...
Association of gait and balance disorders with age-related white matter changes: the LADIS studyH Baezner
Mannheim University Hospital, University of Heidelberg, Department of Neurology, Theodor Kutzer Ufer, D 68135 Mannheim, Germany
Neurology 70:935-42. 2008..We aimed at determining the influence of ARWMC on different objective measures of gait and balance...
Model-free group analysis shows altered BOLD FMRI networks in dementiaSerge A R B Rombouts
Department of Physics and Medical Technology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Hum Brain Mapp 30:256-66. 2009..The technique is more sensitive than the commonly applied model-based method. Consistent with other research, we show that networks of activation and deactivation show decreased reactivity in dementia...
Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRIM W G Vandenbroucke
Department of Physics and Medical Technology, VU Medical Center, Amsterdam, The Netherlands
Neuroimage 21:173-80. 2004..Group analysis in standard space may not be appropriate for studies of a complex structure such as the MTL, particularly not in aging and dementia...
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI studyRutger Goekoop
Department of Neurology Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Brain 129:141-57. 2006....
CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosisTineke van Veen
Department of Molecular Cell Biology and Immunology, VU University Medical Centre, Amsterdam, The Netherlands
J Neuroimmunol 190:157-64. 2007..In summary, our multifaceted study supports the notion that polymorphisms in CCL5 and CCR5 modify the course of MS...
A three-year, multi-parametric MRI study in patients at presentation with CISMaria A Rocca
Neuroimaging Research Unit, Dept of Neurology, Scientific Institute and University Ospedale, San Raffaele, Via Olgettina, 60, 20132 Milan, Italy
J Neurol 255:683-91. 2008..To define the extent of overall brain damage in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis (MS) and to identify non-conventional magnetic resonance (MR) metrics predictive of evolution to definite MS...
Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced?Leonardo Pantoni
Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy
Stroke 33:2827-33. 2002..We aimed to compare 6 widely used rating scales for leukoaraiosis and to calculate conversion coefficients of the score of 1 scale in the score of a second scale...
The FAS-670 polymorphism influences susceptibility to multiple sclerosisT van Veen
Department of Neurology, VU Medical Centre, De Boelelaan 1117, 1007 MB, Amsterdam, The Netherlands
J Neuroimmunol 128:95-100. 2002..We observed similar brain and lesion volumes in carriers and noncarriers of FAS-670*G. These data suggest that FAS-670*G decreases the risk of developing MS, but does not affect the course of disease...
The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementiaAntonio J Bastos-Leite
Image Analysis Center, VU University Medical Center, Amsterdam, The Netherlands
Stroke 38:3182-5. 2007..Therefore, our purpose was to investigate the relative contribution of cerebrovascular disease and MTA to cognitive impairment in patients fulfilling diagnostic criteria for VaD...
Whole brain analysis of T2* weighted baseline FMRI signal in dementiaSerge A R B Rombouts
Department of Physics and Medical Technology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Hum Brain Mapp 28:1313-7. 2007..We conclude that in FMRI studies of dementia, not only the dynamic BOLD signal (activation and deactivation) but also the average baseline signal is diminished in certain regions. The method we applied may also be used in task-rel..
Frontal-striatal dysfunction during planning in obsessive-compulsive disorderOdile A van den Heuvel
Departments of Psychiatry, Anatomy, and Radiology and Outpatient Clinic for Anxiety Disorders, GGZ Buitenamstel, VU University Medical Center, Amsterdam, The Netherlands
Arch Gen Psychiatry 62:301-9. 2005..Because the described frontal-striatal dysfunction in OCD is independent of state anxiety and disease symptom severity, we conclude that executive impairment is a core feature in OCD...
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter studyZhaleh Khaleeli
Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, London, United Kingdom
Ann Neurol 63:790-3. 2008..These predictors of long-term disability provide some insight into disease progression...
Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibilityJeroen J G Geurts
Department of Radiology, MR Center for MS Research, VU University Medical Center, Amsterdam, The Netherlands
J Magn Reson Imaging 20:366-71. 2004..Moreover, the quantification precision of a metabolite in a single spectrum appears to be a reliable measure for its reproducibility in a longitudinal study...
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosisCatharina M P Vos
Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neurobiol Dis 20:953-60. 2005..This study shows for the first time that in MS brain changes in the vasculature take place not only in focal lesions but also in DAWM as detected by postmortem MRI...
CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosisTineke van Veen
Department of Neurology, VU University Medical Centre, De Boelelaan 1117, 1007 MB, Amsterdam, The Netherlands
J Neuroimmunol 140:188-93. 2003..We observed no effects of the polymorphisms on brain and lesion volumes. These data suggest that the polymorphisms under investigation do not affect the risk of developing MS and have no influence on the course of disease...
Lack of association between antimyelin antibodies and progression to multiple sclerosisJens Kuhle
Department of Research, University Hospital, Basel, Switzerland
N Engl J Med 356:371-8. 2007..An increased risk of progression to clinically definite multiple sclerosis in patients with serum antibodies against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) has been reported...
Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS StudyRaija Ylikoski
Memory Research Unit, Department of Neurology, University of Helsinki, Helsinki, Finland
Dement Geriatr Cogn Disord 24:73-81. 2007..The objective of this study was to compare the results of the two scales among subjects with various degrees of white matter hyperintensities (WMHs)...
Raloxifene affects brain activation patterns in postmenopausal women during visual encodingS J Neele
Department of Endocrinology, Academic Hospital Vrije Universiteit, 1007 MB Amsterdam, The Netherlands
J Clin Endocrinol Metab 86:1422-4. 2001..The mean recognition test and the simple photic stimulation test showed no treatment interactions. Our results show that raloxifene affects brain activation patterns upon visual encoding in postmenopausal women...
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitusG J Biessels
The Alzheimer Center, Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 77:304-7. 2006..The risk of Alzheimer's disease (AD) is increased in type 2 diabetes (DM2). This increased risk has been attributed to vascular comorbidity, but other mechanisms, such as accelerated ageing of the brain, have also been implicated...
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosisI J van den Elskamp
Department of Radiology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Mult Scler 14:764-9. 2008..At present, a power analysis using black hole (BH) evolution as primary outcome measure has not been performed...
Subtraction MR images in a multiple sclerosis multicenter clinical trial settingBastiaan Moraal
Departments of Radiology, MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
Radiology 250:506-14. 2009....
White matter lesions and hippocampal atrophy in Alzheimer's diseaseFrank-Erik de Leeuw
Alzheimer Center, Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
Neurology 62:310-2. 2004..A linear relation was found between WML and HA, especially for WML in the frontal and parieto-occipital regions. The results suggest that vascular pathology and typical AD pathology (HA) are related...
Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly malesRutger Goekoop
Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neuropsychopharmacology 31:1508-18. 2006..Behaviorally, such neurofunctional effects may actively block decreased memory performance as a result of context-dependency. The validity of these predictions can be tested in large-scale clinical trials...
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation"Arnaud Charil
Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University Ospedale San Raffaele, Milan, Italy
Lancet Neurol 5:841-52. 2006..In this review we will report on the conclusions of this international consensus, which should represent a first step beyond the concept of "no better explanation", and inform future diagnostic criteria for multiple sclerosis...
Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS StudyHanna Jokinen
Department of Psychology, University of Helsinki, Helsinki, Finland
J Neurol Neurosurg Psychiatry 78:491-6. 2007..Previous research has indicated that corpus callosum atrophy is associated with global cognitive decline in neurodegenerative diseases, but few studies have investigated specific cognitive functions...
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman
Department of Neurology, Free University Medical Center in Amsterdam, PO Box 4075, 1007 MB Amsterdam, The Netherlands
Neurology 70:1134-40. 2008..Guidance is also provided on the ethics of alternative trial designs and the balance between study subject burden and risk, scientific rationale and interpretability of trial outcomes...
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging resultsJ M Nielsen
Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Mult Scler 13:717-21. 2007..Recently, a clinical classification system was described to determine whether symptoms and signs of patients presenting with a first episode suggestive of multiple sclerosis (MS) indicate the presence of monofocal or multifocal disease...
Nonlinear changes in brain activity during continuous word repetition: an event-related multiparametric functional MR imaging studyR E Hagenbeek
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 28:1715-21. 2007..Our aim was to identify linear changes in brain activation and, what is more interesting, nonlinear changes in brain activation as a function of extended word repetition...
The distribution of new enhancing lesion counts in multiple sclerosis: further explorationsIj van den Elskamp
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
Mult Scler 15:42-9. 2009..We examined whether there are superior alternatives for the currently proposed negative binomial (NB) distribution...
Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocolO W M Meijer
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 29:906-10. 2008..This study evaluates the volumetric changes of VS after radiosurgery and proposes a radiologic follow-up program...
Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENAVeronica Neacsu
MS Center Amsterdam, VU University Medical Center, Department of Radiology, Amsterdam, The Netherlands
J Magn Reson Imaging 28:559-65. 2008..To investigate whether multiple sclerosis (MS) atrophy can be assessed by SIENA and SIENAX software using other image types from MS research protocols than T1-weighted images without contrast agent, which are not always available...
At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities onlyJ N P Zwemmer
Department of Neurology, MS Center, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Mult Scler 14:428-30. 2008..We propose that these cases represent the most pure form of PPMS, even though according to currently applied criteria this diagnosis can not be made in the absence of focal lesions on MRI...
Fetal lung volume: three-dimensional ultrasonography compared with magnetic resonance imagingF A Gerards
Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands
Ultrasound Obstet Gynecol 29:533-6. 2007..The purpose of this study was to assess the agreement of lung volumes measured with 3D ultrasonography and MRI in uncomplicated pregnancies...
Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease typesH Vrenken
Department of Radiology, MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 31:541-8. 2010..This study aimed to characterize DAWM in vivo by using 4 quantitative MR imaging measures and to explore differences between MS disease types...
